More articles from Endo II: Management of Thyroid Cancer

You have access
Does elevated TSH in hypothyroid state elevate ovarian FDG uptake?
Sang-Geon Cho, Ari Chong, Ho-chun Song, Jong-Ryool Oh, Sae-Ryung Kang, Jahae Kim, Su Woong Yoo, Sun-Pyo Hong, Jung-Joon Min and Hee-Seung Bom

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 311;
You have access
Characterization of salivary gland side effects up to 7 days after ¹³¹I therapy: Updated report of the Thyroid Cancer Survivors’ Association, Inc. (ThyCa) national survey
Jordan Hall, Pejman Kharazi, Douglas Van Nostrand, Gauri Khorjekar, Michael Brennan, Bryan McIver, Mihriye Mete and Gary Bloom

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 306;
You have access
Clinical characteristics related to increased lung uptake on I-131 post-therapeutic scans in thyroid cancer
Narae Lee, Sung Hoon Kim, Woo Hee Choi, Eun Ji Han and Hyun Su Choi

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 312;
You have access
Characterization of salivary gland side effects secondary to ¹³¹I therapy: Report of the Thyroid Cancer Survivors’ Association, Inc. (ThyCa) national survey for intermediate and long term results
Jordan Hall, Pejman Kharazi, Douglas Van Nostrand, Gauri Khorjekar, Michael Brennan, Bryan McIver, Mihriye Mete and Gary Bloom

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 308;
You have access
SPECT-CT characterization of oral activity seen on radioiodine scintigraphy
Hatice Savas, Ka kit Wong, Berna Saglik and Anca Avram

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 310;
You have access
Discordance in 68Ga-DOTANOC and 177Lu-DOTATATE uptake in diagnostic and post-therapy scans in patients with medullary thyroid cancer
Nishikant Damle, Santosh Gupta, Chandrasekhar Bal, Praveen Kumar and Krishan K Agarwal

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 307;
You have access
The value of ^99mTc-DTPA orbital SPECT in the drug treatment of thyroid associated ophthalmopathy
Yi Lu, Li Feng, Jin Jianhua and Jian-zhong Liu

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 309;

Main menu

User menu

Search

More articles from Endo II: Management of Thyroid Cancer